[Symptomatic therapy in polyneuropathies].
D000449:Aldehyde Reductase / Q000037:antagonists & inhibitors; D000700:Analgesics / Q000627:therapeutic use; D002422:Causalgia / Q000188:drug therapy; D003131:Combined Modality Therapy; D006801:Humans; D009120:Muscle Cramp / Q000188:drug therapy; D010523:Peripheral Nervous System Diseases / Q000188:drug therapy*; D026741:Physical Therapy Modalities / Q000379:methods; D011115:Polyneuropathies / Q000188:drug therapy*; D011619:Psychotropic Drugs / Q000627:therapeutic use; D014815:Vitamins / Q000627:therapeutic use
D000700:Analgesics; D011619:Psychotropic Drugs; D014815:Vitamins; D000449:Aldehyde Reductase
Symptomatische Therapie bei Polyneuropathien.